L. Cui

Olfactory event-related potentials in normal human subjects: effects of age and gender.

A. Starr, W. Evans, L. Cui, 1995, Electroencephalography and clinical neurophysiology.

The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and alpha-tocopherol. Parkinson Study Group.

P. Lewitt, D. Oakes, L. Cui, 1997, Movement disorders : official journal of the Movement Disorder Society.

Levodopa drug holiday versus drug dosage reduction in Parkinson's disease

C. Tanner, M. Mcdermott, C. Goetz, 1994 .

A summary of the evidence and evaluation of the effectiveness of nonpharmacological interventions for mild cognitive impairment

Yanhui Liu, Yunyun Wang, L. Cui, 2019 .

[Olfactory event-related potentials to isoamyl acetate in congenital anosmia].

W. Evans, L. Cui, 1998, Zhonghua yi xue za zhi.

The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and α‐tocopherol

David Oakes, Peter A. LeWitt, D. Oakes, 1997 .

Olfactory event-related potentials to amyl acetate in congenital anosmia.

W. Evans, L. Cui, 1997, Electroencephalography and clinical neurophysiology.